podophyllotoxin has been researched along with Blood Diseases in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (83.33) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brooks, SL; Buchanan, GR; Eshelman, DA; Fischbach, L; Harris, TR; Long, ZB; Oeffinger, KC; Tomlinson, GE | 1 |
| Aisner, J; Van Echo, DA; Whitacre, M; Wiernik, PH | 1 |
| Hansen, HH; Lau, ME; Nissen, NI; Pedersen, H | 1 |
| Gauthier, H; Huguenin, P; Lheritier, J; Mathe, G; Morin, P; Parrot, R; Poisson, M; Pouillart, P; Thy, TH | 1 |
| Donsimoni, R; Gerota, J; Gumus, Y; Hingh, B; Lam, Y; Lotz, JP; Machover, D; Malassagne, B; Marsiglia, H; Tulliez, M | 1 |
| Birch, R; Greco, FA; Sarma, P; Wolff, SN | 1 |
| Birch, R; Einhorn, LH; Greco, FA; Troner, M; Walther, PJ; Williams, SD | 1 |
| Bartolucci, AA; Gockerman, JP; Nelson, MO; Silberman, H; Stein, R; Velez-Garcia, E | 1 |
| Bundy, BN; DiSaia, PJ; Muss, H; Twiggs, LB | 1 |
| Kooiman, A; Neijt, JP; ten Bokkel Huinink, WW; van der Burg, ME; van Oosterom, AT; van Putten, WL; Vermorken, JB; Vriesendorp, R | 1 |
| de Vries, EG; Mulder, NH; Postmus, PE; Sleijfer, DT; Vriesendorp, R; Willemse, PH | 1 |
7 trial(s) available for podophyllotoxin and Blood Diseases
| Article | Year |
|---|---|
Comparison of the use of teniposide and vincristine in combination chemotherapy for non-Hodgkin's lymphoma.
Topics: Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Hematologic Diseases; Humans; Kidney Diseases; Lymphoma; Podophyllotoxin; Prednisolone; Teniposide; Vincristine | 1982 |
Phase I trial of a new form of an oral administration of VP-16-213.
Topics: Administration, Oral; Adult; Aged; Capsules; Clinical Trials as Topic; Drug Evaluation; Etoposide; Female; Hematologic Diseases; Humans; Male; Middle Aged; Neoplasms; Podophyllotoxin | 1979 |
Phase I-II study of two consecutive courses of high-dose epipodophyllotoxin, ifosfamide, and carboplatin with autologous bone marrow transplantation for treatment of adult patients with solid tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Central Nervous System Diseases; Combined Modality Therapy; Drug Administration Schedule; Drug Evaluation; Female; Hematologic Diseases; Humans; Ifosfamide; Male; Middle Aged; Neoplasms; Podophyllotoxin; Pregnancy; Transplantation, Autologous | 1991 |
Randomized dose-response evaluation of etoposide in small cell carcinoma of the lung: a Southeastern Cancer Study Group Trial.
Topics: Carcinoma, Small Cell; Clinical Trials as Topic; Dose-Response Relationship, Drug; Etoposide; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin; Random Allocation | 1986 |
Phase II study of etoposide for carcinoma of the prostate.
Topics: Blood Cell Count; Clinical Trials as Topic; Drug Evaluation; Etoposide; Hematologic Diseases; Humans; Male; Podophyllotoxin; Prostatic Neoplasms | 1986 |
Phase II evaluation of etoposide in refractory multiple myeloma: a Southeastern Cancer Study Group Trial.
Topics: Clinical Trials as Topic; Drug Evaluation; Etoposide; Female; Hematologic Diseases; Humans; Male; Middle Aged; Multiple Myeloma; Podophyllotoxin | 1986 |
Teniposide in epithelial ovarian carcinoma: a phase II trial of the Gynecologic Oncology Group.
Topics: Adult; Aged; Clinical Trials as Topic; Drug Evaluation; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Middle Aged; Ovarian Neoplasms; Podophyllotoxin; Prognosis; Teniposide | 1986 |
5 other study(ies) available for podophyllotoxin and Blood Diseases
| Article | Year |
|---|---|
Incidence and clinical relevance of abnormal complete blood counts in long-term survivors of childhood cancer.
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Blood Cell Count; Child; Child, Preschool; Cohort Studies; Female; Follow-Up Studies; Hematologic Diseases; Humans; Incidence; Infant; Infant, Newborn; Male; Neoplasms; Podophyllotoxin; Prognosis; Survivors | 2006 |
A phase I trial of continuous infusion VP16-213 (etoposide).
Topics: Adult; Aged; Drug Evaluation; Etoposide; Female; Heart Diseases; Hematologic Diseases; Humans; Infusions, Parenteral; Male; Middle Aged; Neoplasms; Podophyllotoxin | 1982 |
Treatment of malignant gliomas and brain metastases in adults with a combination of adriamycin, VM 26, and CCNU. Results of a phase II trail.
Topics: Adult; Aged; Brain Neoplasms; Doxorubicin; Drug Therapy, Combination; Drug Tolerance; Female; Glioma; Hematologic Diseases; Humans; Intracranial Pressure; Lomustine; Male; Middle Aged; Nausea; Neoplasm Metastasis; Nitrosourea Compounds; Podophyllotoxin; Teniposide; Vomiting | 1976 |
Teniposide (VM-26) in patients with advanced refractory ovarian cancer: a phase II study of the Netherlands Joint Study Group for Ovarian Cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female; Hematologic Diseases; Humans; Nausea; Ovarian Neoplasms; Podophyllotoxin; Prognosis; Teniposide | 1987 |
High-dose teniposide for refractory malignancies: a phase I study.
Topics: Adult; Aged; Alopecia; Drug Evaluation; Female; Hematologic Diseases; Humans; Male; Middle Aged; Nausea; Neoplasms; Podophyllotoxin; Skin Diseases; Teniposide | 1986 |